2013

2013 Grants Awarded
“Targeting Core Signaling Networks in Mucinous Adenocarcinoma of the Appendix”
Andrew Lowy, MD, Moores Cancer Center, University of California, San Diego
$50,000/2-year
Awarded in memory of PMPRF founder and former president, Lisa Luciano.
Research Update from Dr. Andrew Lowy, MD dated 08-2015
Research Update from Dr. Andrew Lowy, MD dated 02-2016
Research Update from Dr. Andrew Lowy, MD dated 03-2016
Final Research Update from Dr. Andrew Lowy, MD dated 10-2016

“Carcinoembryonic Antigen – A Pro-Angiogenic Factor in Pseudomyxoma Peritonei – is a Potential Target for Therapy”
Principal Investigator: Peter Thomas, Ph.D. Surgery and Biomedical Sciences, Creighton University
$25,000/2-year
Awarded in memory of founding PMPRF board member and former treasurer, Michael Dvorsky.
Research update from Peter Thomas, Ph.D dated 07-2015
Research update from Peter Thomas, Ph.D dated 02-2016
Research update from Peter Thomas, Ph.D dated 02-2016
Research update from Peter Thomas, Ph.D dated 09-2016
Associated Publication: “Patient‐derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment” (Cancer Med. 2016 Apr; 5(4): 711–719)

“PMP: Biologic Foundations for New Treatment Options”
Principal Investigator: Venkatesh Govindarajan, Ph.D. Department of Surgery, Creighton University
$25,000/2-year
Awarded in memory of founding PMPRF board member and former treasurer, Michael Dvorsky.
Research update from Venkaesh Govindarajan, Ph.D dated 06-2015
Research update from Venkaesh Govindarajan, Ph.D dated 10-2015
Research update from Venhaesh Govindarajan, Ph.D dated 03-2016
*Dr. Govindarajan’s 2013 study was completed ahead of schedule
Associated Publication: “Patient‐derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment” (Cancer Med. 2016 Apr; 5(4): 711–719)